Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23734)

• Formulation Name: Enzalutamide 40mg capsule
• Company: Astellas

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Enzalutamide	(DMGL19D)	Prostate cancer	2C82.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Butylhydroxyanisole	(E00308)	24667	Antimicrobial preservative; Antioxidant
Ferric oxide black	(E00522)	16211978	Colorant
Gelatin	(E00630)	Not Available	Other agent
Glycerin	(E00026)	753	Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Sorbitan tristearate	(E00516)	17800859	Dispersing agent; Emulsifying agent; Solubilizing agent; Surfactant; Suspending agent; Vaccine adjuvant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent